BioSpace News Archive

Policy

Roche receives FDA approval for VENTANA MMR RxDx Panel to identify dMMR solid tumour patients and pMMR endometrial cancer patients eligible for KEYTRUDA

Roche announced US Food and Drug Administration approval of a label expansion for the VENTANA MMR RxDx Panel.

August 11, 2022
·
7 min read
Business

Evotec SE Reports Results for the First Half-year 2022 and Provides Corporate Updates

Other non-operating result of € (89.8) m (H1 2021: € 106.1 m) explained by the non-cash fair value adjustments of the equity investment in publicly listed Exscientia plc.

August 11, 2022
·
8 min read
Business

Novozymes delivers strong half year results and narrows full-year outlook upwards

Novozymes delivers 10% organic sales growth and an EBIT-margin of 26% in the first half of the year, with 18% organic sales growth in DKK.

August 11, 2022
·
4 min read
Business

Oncopeptides publishes Q2 report 2022

Oncopeptides AB, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, publishes the report for the second quarter 2022.

August 11, 2022
·
3 min read
Policy

Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer

The Menarini Group and Stemline Therapeutics announced that the U.S. Food and Drug Administration has accepted the Company’s New Drug Application for elacestrant, an investigational selective estrogen receptor degrader, for patients with ER+/HER2- advanced or metastatic breast cancer.

August 11, 2022
·
5 min read
Pharm Country

Athenex, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants

Athenex intends to use the net proceeds from the proposed offering to fund ongoing clinical development for its product candidates and for working capital and other general corporate purposes.

August 11, 2022
·
4 min read
Immunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ PanCan-d test

The California Department of Public Health has granted Immunovia, Inc., the American subsidiary of Immunovia AB, a Clinical and Public Health Laboratory license, allowing physicians in California to order the IMMray PanCan-d test for their patients.

August 11, 2022
·
2 min read
Business

Evelo Biosciences Announces Succession Plan

Evelo Biosciences, Inc. announced the succession plan for Simba Gill, Ph.D., to transition from his roles as Chief Executive Officer and President to the role of Chair of the Board of Directors and return to Flagship Pioneering to help launch, grow, and guide bioplatform companies.

August 11, 2022
·
7 min read
Business

Evelo Biosciences Announces Second Quarter 2022 Financial Results and Business Highlights

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, reported financial results and business highlights for the second quarter 2022.

August 11, 2022
·
10 min read
Business

Science 37 Reports Second Quarter 2022 Financial Results

Science 37 Holdings, Inc., the Agile Clinical Trial Operating System™, reported its financial results for the quarter ended June 30, 2022.

August 11, 2022
·
17 min read